San Jose, California (PRWEB) June 30, 2014
Follow us on LinkedIn. – The cell culture and tissue market has undergone significant changes and developments over the past two decades. Cell and tissue culture has evolved into a specialized field of science that facilitates artificial growth of cells. Advances in biotechnology and life sciences research coupled with expanding application areas are expected to drive growth in the market. Growth will also be fueled by growing interest in biopharmaceutical therapeutics including biosimilars, human and veterinary vaccines. Increased competition, patent expiries, R&D spends, growing interest in regenerative medicine, and increasing number of protein-based drugs in the final phases of testing will help lend traction to market growth.
The cell culture market is currently witnessing a shift from conventional serum-supplemented media to serum-free and animal component free media. With demand for biopharmaceuticals, particularly monoclonal antibodies growing rapidly, there exists significant opportunities in store for mammalian cells that are the preferred hosts for production of complex protein therapeutics. In addition, the development of novel technologies such as automated screening methods, enhanced expression systems, and cell line engineering have resulted in more efficient yields by mammalian cell culture. Increasing adoption of revolutionary 3D cell culture technology is expected to help overcome the drawbacks associated with 2D cell culture. Another key trend in the market is the development of highly complicated techniques for maximizing protein expression and cell density.
As stated by the new market research report on Cell and Tissue Culture Supplies, the United States represents the largest market worldwide. Asia-Pacific represents the fastest growing market with a CAGR of 9.9% over the analysis period. Lower operational costs, increasing demand for bio-manufacturing, rising interest in stem cell research, higher investment in product development by major companies in China and Japan, and emergence of local companies, represent factors driving growth in the region.
Major players covered in the report include Affymetrix Inc., AMRESCO Inc., BD Biosciences, Cell Culture Technologies LLC, Corning Inc., EMD Millipore, Irvine Scientific Inc., Lonza Biologics Plc, MP Biomedicals LLC, PromoCell GmbH, Sera Laboratories International Ltd., and Sigma-Aldrich Corporation among others.
The research report titled “Cell and Tissue Culture Supplies: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, growth drivers, segmental analysis, mergers, acquisitions, and other strategic industry activities of major global and regional players. The report provides market estimates and projections for all major geographic markets, such as the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe), Asia-Pacific (China, India and Rest of Asia-Pacific), Latin America (Brazil and Rest of Latin America) and Rest of World markets. Product segments analyzed include Media, Sera and Reagents.
For more details about this comprehensive market research report, please visit – http://www.strategyr.com/Cell_Tissue_Culture_Supplies_Market_Report.asp.
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes 1500+ full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Web Site: http://www.StrategyR.com/